Case study – PPIs: reviewing treatment for gastro-oesophageal reflux disease

Gastro-oesophageal reflux is common, with 15-20% of Australians experiencing heartburn at least once a week. Proton pump inhibitors (PPIs) are one of the most commonly prescribed medicines in general practice with more than 20 million prescriptions dispensed in 2016–17, and some patients being prescribed PPIs for several years.

The latest NPS MedicineWise case study, PPIs: reviewing treatment for gastro-oesophageal reflux disease (GORD) focuses on the important role pharmacists play in management of GORD.

This case study will provide you with key strategies to assist patients with symptoms of GORD, including treatment with PPIs, lifestyle changes, referral for stepping down or stopping PPI therapy if appropriate, and support for patients.

Expert commentary is provided by Prof Geoff Hebbard, the Director of Gastroenterology and Hepatology at The Royal Melbourne Hospital. The content is CPD-accredited with a customised version for pharmacists to earn up to 1 hour of Group 2 CPD (or 2 CPD credits).

You can also earn CPD credits by participating in other activities which cover a wide range of topics, such as Pharmacy Practice Reviews and online learning courses, including modules on management of infections, medication safety training and adverse event reporting.


Previous Fancy a $174,000-a-year salary?
Next Students head to business plan finals

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.